Latest On-Demand Webinars

Biotherapeutic drugs are complex and can perform their function through interactions with more than one target molecule. During development and quality control, a range of analytical technologies are used to characterize biotherapeutic drugs in terms of their structural integrity and activity. Ligand-binding assays are relevant for characterization and quantitation of the functional drug, however current analytical approaches may no longer be sufficient for analysis of emerging drug modalities.
Biacore™ assays are based on ligand binding and used in development and characterization of drug product using active concentration measurements, target binding, potency (E50)
and Fc receptor (FcR) analysis.

High concentrations of human lactoferrin (hLF) in human milk offer health benefits for infants and adults, including nourishment and growth support.
Recombinant hLF (rhLF) has been expressed in yeast at an industrial scale, with the aim of making it affordable and accessible as a supplement.
This webinar takes a deep dive into how rhLF can be characterized and analyzed to ensure its safety for consumption in clinical studies.
Our expert speaker will cover how various analytical techniques – including microfluidic modulation spectroscopy – can confirm identity, assess purity and impurities, measure size and investigate the structure of rhLF, as well as compare it to native hLF.

Using data from a recent study, our expert speaker will demonstrate how the new readout platform improves ligand hit quality, and how TIMS offers potential for an expanded scope of AS-MS assays.

The COVID-19 pandemic significantly affected the spread of respiratory pathogens, but their circulation is now returning to pre-pandemic levels.

Attend this webinar to discover how direct analysis in real time (DART), in combination with high-resolution mass spectrometry (HRMS), allows the generation of reliable analytical results much faster and easier than alternative techniques.

In this webinar, you’ll discover how SPR can be multiplexed and automated to enable high-throughput, data-rich drug candidate screening against multiple target proteins.

Raw materials identification (RMID) is a crucial regulatory step required before drug manufacturing. Raman spectroscopy is well-suited to making the process simpler, yet some spectrometers are challenged by light-blocking containers or struggle to reach compliance standards.

Cell and gene therapies harness the power of cells or genetic material to treat, cure or prevent diseases. These cutting-edge therapeutics have the potential to revolutionize medical treatments, especially for conditions that were previously thought to be incurable, including genetic disorders, cancer and degenerative conditions.

Dr. Yuan Liu from Indiana University will be joining Technology Networks to provide a comprehensive overview of this promising field, paving the way for potential therapeutics.

In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics.